Stockreport

Tevogen Bio Secures $6 Million Series C Preferred Stock Investment

Tevogen Bio Holdings Inc.  (TVGN) 
PDF WARREN, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech [Read more]